메뉴 건너뛰기




Volumn 80, Issue 5, 2012, Pages 1056-1062

Long-term results of two prospective bladder-sparing trimodality approaches for invasive bladder cancer: Neoadjuvant chemotherapy and concurrent radio-chemotherapy

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; METHOTREXATE; VINBLASTINE;

EID: 84868207308     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.07.045     Document Type: Article
Times cited : (55)

References (23)
  • 5
    • 84860243695 scopus 로고    scopus 로고
    • Selective bladder preservation with curative intent for muscle-invasive bladder cancer: A contemporary review
    • F. Koga, K. Kihara Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review Int J Urol 19 2012 388 401
    • (2012) Int J Urol , vol.19 , pp. 388-401
    • Koga, F.1    Kihara, K.2
  • 6
    • 0033759699 scopus 로고    scopus 로고
    • Invasive bladder cancer: A single-institution experience with bladder-sparing approach
    • A. Zapatero, C. Martín de Vidales, A. Marín Invasive bladder cancer: a single-institution experience with bladder-sparing approach Int J Cancer 90 2000 287 294
    • (2000) Int J Cancer , vol.90 , pp. 287-294
    • Zapatero, A.1    Martín De Vidales, C.2    Marín, A.3
  • 7
    • 77953870387 scopus 로고    scopus 로고
    • Updated results of bladder-sparing trimodality approach for invasive bladder cancer
    • A. Zapatero, C. Martin de Vidales, R. Arellano Updated results of bladder-sparing trimodality approach for invasive bladder cancer Urol Oncol 28 2010 368 374
    • (2010) Urol Oncol , vol.28 , pp. 368-374
    • Zapatero, A.1    Martin De Vidales, C.2    Arellano, R.3
  • 8
    • 0028969271 scopus 로고
    • Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
    • J.D. Cox, J. Stetz, T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radat Oncol Biol Phys 31 1995 1341 1346
    • (1995) Int J Radat Oncol Biol Phys , vol.31 , pp. 1341-1346
    • Cox, J.D.1    Stetz, J.2    Pajak, T.F.3
  • 10
    • 8844275874 scopus 로고    scopus 로고
    • Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: Long-term results
    • DOI 10.1002/cncr.20654
    • D.T. Danesi, G. Arcangeli, E. Cruciani Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results Cancer 101 2004 2540 2548 (Pubitemid 39532283)
    • (2004) Cancer , vol.101 , Issue.11 , pp. 2540-2548
    • Tirindelli Danesi, D.1    Arcangeli, G.2    Cruciani, E.3    Altavista, P.4    Mecozzi, A.5    Saracino, B.6    Orefici, F.7
  • 11
    • 79952126458 scopus 로고    scopus 로고
    • Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer
    • A. Choudhury, R. Swindell, J.P. Logue Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer J Clin Oncol 29 2011 733 738
    • (2011) J Clin Oncol , vol.29 , pp. 733-738
    • Choudhury, A.1    Swindell, R.2    Logue, J.P.3
  • 12
    • 60249085656 scopus 로고    scopus 로고
    • Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: Long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy
    • E. Solsona, M.A. Iborra Climent Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy Eur Urol 55 2009 911 919
    • (2009) Eur Urol , vol.55 , pp. 911-919
    • Solsona, E.1    Climent, M.A.I.2
  • 13
    • 63149142104 scopus 로고    scopus 로고
    • Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy
    • D.S. Kaufman, K.A. Winter, W.U. Shipley Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy Urology 73 2009 833 837
    • (2009) Urology , vol.73 , pp. 833-837
    • Kaufman, D.S.1    Winter, K.A.2    Shipley, W.U.3
  • 14
    • 84857658866 scopus 로고    scopus 로고
    • Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: The MGH experience
    • J.A. Efstathiou, D.Y. Spiegel, W.U. Shipley Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience Eur Urol 61 2012 705 711
    • (2012) Eur Urol , vol.61 , pp. 705-711
    • Efstathiou, J.A.1    Spiegel, D.Y.2    Shipley, W.U.3
  • 15
    • 78650023934 scopus 로고    scopus 로고
    • Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: Results of a multicenter prospective study (GETUG 97-015)
    • J.L. Lagrange, C. Bascoul-Mollevi, L. Geoffrois Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015) Int J Radiat Oncol Biol Phys 79 2011 172 178
    • (2011) Int J Radiat Oncol Biol Phys , vol.79 , pp. 172-178
    • Lagrange, J.L.1    Bascoul-Mollevi, C.2    Geoffrois, L.3
  • 16
    • 84859880855 scopus 로고    scopus 로고
    • Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer
    • N.D. James, S.A. Hussain, E. Hall Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer N Engl J Med 366 2012 1477 1488
    • (2012) N Engl J Med , vol.366 , pp. 1477-1488
    • James, N.D.1    Hussain, S.A.2    Hall, E.3
  • 17
    • 80052764839 scopus 로고    scopus 로고
    • Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: A comparative study
    • P. Zehnder, U.E. Studer, E.C. Skinner Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study J Urol 186 2011 1261 1268
    • (2011) J Urol , vol.186 , pp. 1261-1268
    • Zehnder, P.1    Studer, U.E.2    Skinner, E.C.3
  • 18
    • 84865486061 scopus 로고    scopus 로고
    • Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients
    • [Epub ahead of print]
    • T.M. Morgan, D.A. Barocas, D.F. Penson Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients Urology 2012 [Epub ahead of print]
    • (2012) Urology
    • Morgan, T.M.1    Barocas, D.A.2    Penson, D.F.3
  • 21
    • 84872669465 scopus 로고    scopus 로고
    • Neoadjuvant Chemotherapy in Invasive Bladder Cancer
    • Advanced Bladder Cancer Overview Collaboration John Wiley & Sons, Ltd Chichester, UK Issue 2
    • Advanced Bladder Cancer Overview Collaboration Neoadjuvant Chemotherapy in Invasive Bladder Cancer Cochrane Library 2008 John Wiley & Sons, Ltd Chichester, UK Issue 2 http://www.update-software.com
    • (2008) Cochrane Library
  • 23
    • 84861101373 scopus 로고    scopus 로고
    • Bladder preservation for localized muscle-invasive bladder cancer: The survival impact of local utilization rates of definitive radiotherapy
    • K.R. Kozak, M. Hamidi, M. Manning Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapy Int J Radiat Oncol Biol Phys 83 2012 e197 e204
    • (2012) Int J Radiat Oncol Biol Phys , vol.83
    • Kozak, K.R.1    Hamidi, M.2    Manning, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.